Viemed Healthcare (VMD) Depreciation & Amortization (CF) (2018 - 2026)

Viemed Healthcare has reported Depreciation & Amortization (CF) for 9 years, with the latest figure at $7.6 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 15.24% year-over-year to $7.6 million; the trailing twelve-month figure through Mar 2026 stood at $29.6 million (up 15.27% YoY), and the FY2025 full-year result was $28.6 million, up 12.79% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $7.6 million, up from $7.6 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $7.6 million in Q1 2026, with the low at $3.4 million in Q1 2022.
• Historically, Depreciation & Amortization (CF) has averaged $5.8 million across 5 years, with a median of $6.3 million in 2024.
• Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) jumped 44.99% — and 2025, when it advanced 5.22%.
• Viemed Healthcare's Depreciation & Amortization (CF) stood at $4.4 million in 2022, then soared by 35.35% to $5.9 million in 2023, then climbed by 7.55% to $6.4 million in 2024, then increased by 18.91% to $7.6 million in 2025, then gained by 0.67% to $7.6 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $7.6 million (Q1 2026), $7.6 million (Q4 2025), and $7.5 million (Q3 2025), per Business Quant data.